Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Classement en actions #7357
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Prix de l'action
$42.98
Dernière synchronisation: 2024-06-21
Capitalisation boursière
$1.62B
Changement (1 jour)
0.01%
Changement (1 an)
0.00%
Pays
IL
Échange Taro Pharmaceutical Industries Ltd. (TARO)

Catégorie

Marge opérationnelle de Taro Pharmaceutical Industries Ltd. (TARO)
Marge opérationnelle au August 2026 TTM : 3.42%
Selon les derniers rapports financiers et le cours de l'action de Taro Pharmaceutical Industries Ltd., la marge opérationnelle actuelle (TTM) est de 3.42%. À la fin de 2023, elle était de 3.09%.
Historique de la marge opérationnelle pour Taro Pharmaceutical Industries Ltd. de 1999 à 2026
Marge opérationnelle à la fin de chaque année
Année Marge opérationnelle Changez
2026 (TTM) 3.42% 0.00%
2024 3.42% 10.68%
2023 3.09% -90.59%
2022 32.84% -74.41%
2021 128.32% 235.56%
2020 38.24% -13.50%
2019 44.21% -3.43%
2018 45.78% -21.82%
2017 58.56% -9.39%
2016 64.63% 5.71%
2015 61.14% 7.89%
2014 56.67% 15.72%
2013 48.97% 12.32%
2011 43.60% 97.91%
2010 22.03% 24.96%
2009 17.63% 32.46%
2008 13.31% -27.98%
2007 18.48% -166.26%
2006 -27.89% -646.86%
2005 5.10% -2,933.33%
2004 -0.18% -100.76%
2003 23.68% -5.92%
2002 25.17% 15.30%
2001 21.83% 40.75%
2000 15.51% 20.23%
1999 12.90% 0.00%
Marge opérationnelle pour des entreprises similaires ou concurrentes
Entreprise Marge opérationnelle Différence de Marge Opérationnelle Pays
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -93.30%
IN
Qu'est-ce que la Marge opérationnelle d'une entreprise ?
La Marge opérationnelle est un indicateur clé pour évaluer la rentabilité d'une entreprise. Une marge d'exploitation plus élevée est généralement préférable car elle montre qu'une entreprise peut vendre ses produits ou services bien au-dessus de leurs coûts de production. Elle se calcule en divisant les bénéfices par le chiffre d'affaires.